期刊文献+

注射用腺苷蛋氨酸在梗阻性黄疸患者治疗中的作用 被引量:1

暂未订购
导出
摘要 梗阻性黄疸是指排泄胆汁的胆道系统因机械性阻塞致使胆汁无法顺利排泄到肠道所引起的黄疸,是一种临床较常见的病理状态.梗阻性黄疸可以导致机体各系统器官的损害以及相应的病理生理改变,其中最主要的是肝脏损伤,同时其也是导致肝硬化、感染及内毒素血症、门脉高压、出血倾向等并发症的重要诱因[1].作者应用注射用腺苷蛋氨酸(思美泰)联合舒肝宁治疗肝功能损害,并将治疗后肝功能指标变化情况及临床疗效与单用舒肝宁者进行对比,现报道如下.
出处 《肿瘤基础与临床》 2012年第5期450-451,共2页 journal of basic and clinical oncology
  • 相关文献

参考文献4

  • 1Kücükay F,Okten RS,Yurdakul M,et al.Percutaneous management of malignant biliary disease:factors influencing the ability to overcome the stricture[J].Diagn Interv Radiol,2011,17(2):169-173.
  • 2van Delden OM,Laméris JS.Percutaneous drainage and stenting for palliation of malignant bile duct obstruction[J].Eur Radiol,2008,18(3):448-456.
  • 3Boelsterli UA,Rakhit G,Balazs T.Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase,membrane fluidity,and bile flow in rats with ethinyl estradiol-induced cholestasis[J].Hepatology,1983,3(1):12-17.
  • 4杨玲燕,丁厚中.腺苷蛋氨酸治疗梗阻性黄疸术后体会[J].交通医学,2003,17(6):690-691. 被引量:1

二级参考文献2

  • 1Friedel HA, Goa KL,Benfield P,et al. Focus on S- adenosyl -L- methionine. Drugs 1989;3(8) :389-416.
  • 2Boslsterli UA ,Rakhit G, Balasz T. Modulation by S- adenosyl- L - methionine of hepatic Na+ /K+ - ATPase, methionine fluidity, and bile flow in rats with ethinyl estradiol - induced cholestasis. Hepatology 1983;3(1):12-17.

同被引文献9

引证文献1

二级引证文献3

  • 1中国抗癌协会肝癌专业委员会转化治疗协作组,樊嘉.肝癌转化治疗中国专家共识(2021版)[J].中华消化外科杂志,2021,20(6):600-616. 被引量:109
  • 2中国抗癌协会肝癌专业委员会转化治疗协作组,樊嘉,秦叔逵,沈锋,蔡秀军,滕皋军,蔡建强,周俭,陈敏山,李强,刘连新,王伟林,梁廷波,张必翔,孙惠川,谢青,荚卫东,赵明,刘秀峰,毕新宇,黎功,白雪莉,纪元,徐立,王征,朱小东.肝癌转化治疗中国专家共识(2021版)[J].中国实用外科杂志,2021,41(6):618-632. 被引量:124
  • 3Hui-Chuan Sun,Jian Zhou,Zheng Wang,Xiufeng Liu,Qing Xie,Weidong Jia,Ming Zhao,Xinyu Bi,Gong Li,Xueli Bai,Yuan Ji,Li Xu,Xiao-Dong Zhu,Dousheng Bai,Yajin Chen,Yongjun Chen,Chaoliu Dai,Rongping Guo,Wenzhi Guo,Chunyi Hao,Tao Huang,Zhiyong Huang,Deyu Li,Gang Li,Tao Li,Xiangcheng Li,Guangming Li,Xiao Liang,Jingfeng Liu,Fubao Liu,Shichun Lu,Zheng Lu,Weifu Lv,Yilei Mao,Guoliang Shao,Yinghong Shi,Tianqiang Song,Guang Tan,Yunqiang Tang,Kaishan Tao,Chidan Wan,Guangyi Wang,Lu Wang,Shunxiang Wang,Tianfu Wen,Baocai Xing,Bangde Xiang,Sheng Yan,Dinghua Yang,Guowen Yin,Tao Yin,Zhenyu Yin,Zhengping Yu,Bixiang Zhang,Jialin Zhang,Shuijun Zhang,Ti Zhang,Yamin Zhang,Yubao Zhang,Aibin Zhang,Haitao Zhao,Ledu Zhou,Wu Zhang,Zhenyu Zhu,Shukui Qin,Feng Shen,Xiujun Cai,Gaojun Teng,Jianqiang Cai,Minshan Chen,Qiang Li,Lianxin Liu,Weilin Wang,Tingbo Liang,Jiahong Dong,Xiaoping Chen,Xuehao Wang,Shusen Zheng,Jia Fan,无.Chinese expert consensus on conversion therapy for hepatocellular carcinoma(2021 edition)[J].Hepatobiliary Surgery and Nutrition,2022,11(2):227-252. 被引量:56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部